Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-12-12
DOI
10.1038/s41416-018-0352-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma
- (2018) Hailong Ma et al. BRITISH JOURNAL OF CANCER
- Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway
- (2018) Yingnan Wang et al. ORAL ONCOLOGY
- Targeting adenosine in cancer immunotherapy: a review of recent progress
- (2017) Theresa L Whiteside Expert Review of Anticancer Therapy
- Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma
- (2017) Hai-long Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma
- (2017) Manuela Silginer et al. NEURO-ONCOLOGY
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type I Interferon in Chronic Virus Infection and Cancer
- (2017) Laura M. Snell et al. TRENDS IN IMMUNOLOGY
- Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
- (2017) Marco Ruella et al. Cancer Discovery
- Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using Patient-Derived Xenografts
- (2017) Shuyang Sun et al. Theranostics
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Interferon-α Promotes the Expression of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma
- (2017) Hailong Ma et al. Journal of Cancer
- Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
- (2017) Guillermo De Velasco et al. Cancer Immunology Research
- Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes
- (2016) Cherie T. Ng et al. CELL
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO
- (2016) Sijie Fang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Overexpression of stathmin/oncoprotein 18 correlates with poorer prognosis and interacts with p53 in oral squamous cell carcinoma
- (2016) Hai-Long Ma et al. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
- Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma
- (2016) Francesco Sabbatino et al. JNCI-Journal of the National Cancer Institute
- Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
- (2016) Tanguy Y Seiwert et al. LANCET ONCOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma
- (2016) Francesco Sabbatino et al. JNCI-Journal of the National Cancer Institute
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency
- (2015) C. Liu et al. EMBO Molecular Medicine
- XL413, a cell division cycle 7 kinase inhibitor enhanced the anti-fibrotic effect of pirfenidone on TGF-β1-stimulated C3H10T1/2 cells via Smad2/4
- (2015) Shu-fang Jin et al. EXPERIMENTAL CELL RESEARCH
- Immunology and Immunotherapy of Head and Neck Cancer
- (2015) Robert L. Ferris JOURNAL OF CLINICAL ONCOLOGY
- Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue
- (2015) Stephanie Booy et al. PANCREAS
- IFNAR1 Is a Predictor for Overall Survival in Colorectal Cancer and Its mRNA Expression Correlated With IRF7 But Not TLR9
- (2015) Liang-Che Chang et al. MEDICINE
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
- (2014) Netanya G. Sandler et al. NATURE
- Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist
- (2014) D. Levin et al. Science Signaling
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation
- (2012) Jacob Piehler et al. IMMUNOLOGICAL REVIEWS
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- (2012) Bradley N Bidwell et al. NATURE MEDICINE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway
- (2011) Jiao Chen et al. IMMUNOBIOLOGY
- IFN- Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity
- (2011) S. Terawaki et al. JOURNAL OF IMMUNOLOGY
- A Novel Molecular Signature Identified by Systems Genetics Approach Predicts Prognosis in Oral Squamous Cell Carcinoma
- (2011) Chien-Hua Peng et al. PLoS One
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity
- (2010) Paola Rizza et al. AUTOIMMUNITY
- Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis
- (2009) Cherry L Estilo et al. BMC CANCER
- IFN-α wakes up sleeping hematopoietic stem cells
- (2009) Emmanuelle Passegué et al. NATURE MEDICINE
- Critical role for constitutive type I interferon signaling in the prevention of cellular transformation
- (2008) Hui-min Chen et al. CANCER SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started